29 Dec Glanzmann thrombasthenia is a genetic platelet disorder in which the platelet have qualitative or quantitative deficiencies of the fibrinogen. Hematology-dental integrated management in Glanzmann thrombasthenia. Acta Med Colomb [online]. , vol, n.1, pp ISSN PDF | CASO CLÍNICO: paciente de 29 años de edad, primigrávida, con diagnóstico de trombastenia de Glanzmann establecido en la niñez. La finalización del.

Author: Goran Doutaur
Country: Cuba
Language: English (Spanish)
Genre: Career
Published (Last): 13 September 2015
Pages: 37
PDF File Size: 2.20 Mb
ePub File Size: 10.41 Mb
ISBN: 239-3-25203-726-2
Downloads: 65374
Price: Free* [*Free Regsitration Required]
Uploader: Nashakar

Glanzmann’s thrombasthenia

Patients with thrombasthenia typically present with mucocutaneous bleeding at birth or early in infancy. The PFA measures the closure time when blood is passed through collagen-based filters under flow; blood from GT patients fails to plug the filter.

A continually updated database is available on glanzmsnn Internet http: The best way to diagnose GT in its entirety is through mutation analysis. Print this section Print the entire contents of Print the entire contents of article.

Specific roles for surface membrane glycoproteins in platelet function. The PFA assay time will normalize with adequate transfusions.

Genetic glanzmmann is recommended for people with GT and trombastenia de glanzmann families. National Center for Biotechnology InformationU. While fatal bleeding episodes can occur at any point in the lifespan of a patient with GT, the prevalence of severe bleeding does decrease with age. These platelets might not have exactly the same friendly proteins on the surface.

Be sure to follow any maintenance or preventive measures your health care professional has planned for you. InBraunsteiner and Pakesch reviewed trombaxtenia of platelet function and described thrombasthenia as an inherited disease characterized by platelets of normal size that failed to spread onto a surface and did not support clot retraction [ 2 ].


Glanzmann first described this disease in as “hereditary hemorrhagic thrombasthenia” [ 1 ]. Glanzmann thrombasthenia is a rare disorder that affects males and females in equal numbers. Trombastenua RF, Meyer S. There may a slightly higher female preponderance for Glanzmann thrombasthenia.

GT can be a severe hemorrhagic disease, however the prognosis is excellent with careful supportive care.


Severe menorrhagia, which plagues many women with GT and can be seen with menarche, can be treated with high-dose conjugated estrogen intravenously for 24—48 hours, followed by high doses of an oral combination of estrogen—progestin. Glanzmann thrombasthenia is a bleeding disorder that is characterized by prolonged or spontaneous bleeding starting from birth. Type I cytokine receptor: She underwent anterior-posterior nasal packing with no more bleeding after the procedure.

The full terms of the License are available trojbastenia http: Bleeding into the jointsparticularly spontaneous bleeds, are very rare, in contrast to the hemophilias. Phedel, and ITGB3 p. People glanzmaann trombastenia de glanzmann bleed for a longer period of time than people who have the normal amount of clotting factors in their blood. This finding may reflect the added problem of menorrhagia. It can be effectively treated with high doses of progesterone.

If HLA-matched platelets are not available, patients should receive leukocyte-reduced platelets, as this has been shown to reduce the rate of HLA immunization.

It is estimated that one in 1, individuals have GT, though the exact number is unknown. CASR Familial hypocalciuric hypercalcemia. Demonstration of novel gain-of-function mutations of alphaIIbbeta3: The patient was refractory to platelet transfusions, tranexamic acid, and embolization, but responded to bevacizumab.


Published online Jul 8. Local measures include compression, gelatin sponges, fibrin sealants, and topical thrombin.

For a review of pregnancy in women with Glanzmann thrombasthenia, see Siddiq et al. A novel Leu to Pro substitution in the beta3 subunit of the alphaIIbbeta3 integrin in a patient with a variant form of Glanzmann thrombasthenia. Severe menorrhagia ee a frequent clinical problem and is usually associated with an excessively proliferative endometrium caused by estrogen dominance.

Patients trombadtenia severe bleeding episodes should continue to receive platelet transfusions for 48 hours after the cessation of bleeding, and until wound healing has occurred in patients undergoing surgery. It is also more difficult to obtain platelet-rich plasma in patients with thrombocytopenia and in pediatric patients under the testing guidelines.

They will also coordinate with the dentist, surgeon, and anesthesiologist.

Glanzmann’s thrombasthenia: pathogenesis, diagnosis, and current and emerging treatment options

Despite variations in the severity and frequency of bleeding episodes, most GT patients receive blood transfusions [ 3940 ]. This was her third episode of spontaneous non-traumatic epistaxis that needed packing.

Humans have 22 pairs of chromosomes autosomes plus the sex chromosomes X and Y. However, intensive menstrual bleeding does not always respond to typical therapy. General treatment concepts The current standard of treatment of bleeding episodes in patients with GT is the use of local measures alone or in conjunction with anti-fibrinolytic therapy first, followed by platelet transfusion, and rFVIIa if bleeding persists.